KDM1A and acute myeloid leukemia: In particular, in a panel of 21 AML cell lines (representing all subtypes), it was seen that the combination of RA with the LSD1 inhibitor MC2580 (4, see below) impacts on the viability of both LSD1 inhibitors-sensitive and -resistant AML cell lines.